Major advances in cancer treatment over the past three decades have brought about better outcomes.

In recent years, for instance, the introduction of immunotherapy, where the body's immune system is activated to destroy the cancer, has transformed care for many patients.

An upcoming seminar organised by Parkway Cancer Centre will offer further information about immunotherapy, targeted agents, chemotherapy and more.

Called Understanding Cancer And Beyond 2018, the seminar will feature various speakers from the centre.

They will discuss topics including changes in cancer management and what they mean for patients; how latest treatments have made it possible for breast cancer patients to live longer and how newer non-invasive genetic tests can lead to improved early cancer screening.

The experts will also discuss the use of check point inhibitors, a new class of immunotherapy that has been shown to be superior to standard treatments in a wide variety of cancers, including melanoma, lung, bladder, stomach and liver cancer.

CAR T-cell therapy, a rapidly emerging immunotherapy approach in the treatment of blood diseases such as leukaemia and lymphoma, will also be discussed.

The highlight will be the various break-out sessions, during which doctors will address any queries that participants have on specific types of cancer, including blood, lung and gastrointestinal cancers.